| Thomas M Watanabe, | |
|
651 Dunlop Ln, Clarksville, TN 37040-5015 | |
| (931) 502-1370 | |
| Not Available |
| Full Name | Thomas M Watanabe |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 21 Years |
| Location | 651 Dunlop Ln, Clarksville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629284872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 036116691 (Illinois) | Secondary |
| 207P00000X | Emergency Medicine | 44158 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henderson Hospital | Henderson, NV | Hospital |
| Valley Hospital Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shadow Emergency Physicians Pllc | 2860667375 | 94 |
News Archive
More than 60 percent of breast cancer survivors report at least one treatment-related complication even six years after their diagnosis, according to a new study led by a researcher from the Perelman School of Medicine at the University of Pennsylvania.
Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington Beach, CA. The new laboratory will further increase capacity to support Agendia's strong commercial expansion in the U.S. market, as well as the use of multiple Agendia tests in clinical research. MammaPrint, the company's lead product and the only FDA-cleared breast cancer recurrence test, is reimbursed by an increasing number of payers, covering some 100 million lives today.
Jan Scott (Newcastle, UK) and Francesc Colom (Barcelona) have published a review of psychological interventions for bipolar disorder in the Jan 2008 issue of Psychotherapy and Psychosomatics.
Array BioPharma Inc. today announced that it has entered into an agreement with Novartis for the worldwide development of the small-molecule MEK inhibitors ARRY-162, currently in a Phase 1 cancer trial, its back-up, ARRY-300, and other MEK inhibitors.
› Verified 2 days ago
| Entity Name | Shadow Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184795874 PECOS PAC ID: 2860667375 Enrollment ID: O20111212000888 |
News Archive
More than 60 percent of breast cancer survivors report at least one treatment-related complication even six years after their diagnosis, according to a new study led by a researcher from the Perelman School of Medicine at the University of Pennsylvania.
Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington Beach, CA. The new laboratory will further increase capacity to support Agendia's strong commercial expansion in the U.S. market, as well as the use of multiple Agendia tests in clinical research. MammaPrint, the company's lead product and the only FDA-cleared breast cancer recurrence test, is reimbursed by an increasing number of payers, covering some 100 million lives today.
Jan Scott (Newcastle, UK) and Francesc Colom (Barcelona) have published a review of psychological interventions for bipolar disorder in the Jan 2008 issue of Psychotherapy and Psychosomatics.
Array BioPharma Inc. today announced that it has entered into an agreement with Novartis for the worldwide development of the small-molecule MEK inhibitors ARRY-162, currently in a Phase 1 cancer trial, its back-up, ARRY-300, and other MEK inhibitors.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas M Watanabe, 2020 21st Ave S Ste 201, Nashville, TN 37212-4354 Ph: (615) 269-0652 | Thomas M Watanabe, 651 Dunlop Ln, Clarksville, TN 37040-5015 Ph: (931) 502-1370 |
News Archive
More than 60 percent of breast cancer survivors report at least one treatment-related complication even six years after their diagnosis, according to a new study led by a researcher from the Perelman School of Medicine at the University of Pennsylvania.
Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington Beach, CA. The new laboratory will further increase capacity to support Agendia's strong commercial expansion in the U.S. market, as well as the use of multiple Agendia tests in clinical research. MammaPrint, the company's lead product and the only FDA-cleared breast cancer recurrence test, is reimbursed by an increasing number of payers, covering some 100 million lives today.
Jan Scott (Newcastle, UK) and Francesc Colom (Barcelona) have published a review of psychological interventions for bipolar disorder in the Jan 2008 issue of Psychotherapy and Psychosomatics.
Array BioPharma Inc. today announced that it has entered into an agreement with Novartis for the worldwide development of the small-molecule MEK inhibitors ARRY-162, currently in a Phase 1 cancer trial, its back-up, ARRY-300, and other MEK inhibitors.
› Verified 2 days ago
John D Shields, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1771 Madison St, Clarksville, TN 37043 Phone: 931-552-6622 | |
Dr. Malcolm A Steele, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 651 Dunlop Ln, Clarksville, TN 37040 Phone: 931-502-1370 | |
Manickam Krishnamurthy, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 651 Dunlop Ln, Clarksville, TN 37040 Phone: 931-502-1370 | |
Mark A Muiznieks, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 651 Dunlop Lane Clarksville, Clarksville, TN 37040 Phone: 931-502-1370 | |
Dr. Russell Paul Landry Iii, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 651 Dunlop Lane, Clarksville, TN 37040 Phone: 713-430-6095 | |
Dr. Timothy L Obernuefemann, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2320 Wilma Rudolph Blvd, Clarksville, TN 37040 Phone: 931-645-1564 Fax: 931-645-3842 | |
Dr. James Willis Hickerson Jr., MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 651 Dunlop Ln, Clarksville, TN 37040 Phone: 931-502-1370 |